PAREXEL Consulting Experts To Present Insights Into Achieving Regulatory Approval at the 2009 BIO International Convention

Experts from PAREXEL Consulting will present insights into achieving regulatory approval at the BIO International Convention, to be held May 18-21, 2009 at the Georgia World Congress Center in Atlanta, Georgia. PAREXEL Consulting is a business unit of PAREXEL International (Nasdaq: PRXL) and leading global consultancy serving the biopharmaceutical and medical device industries. PAREXEL Consulting experts will be on site at the convention to discuss all aspects of biologics development and commercialization, portfolio analysis, and acquisition due diligence with attendees. For more information about these topics visit http://www.parexelconsulting.com/BIO2009.

On Tuesday, May 19 of the convention, PAREXEL Consulting experts will give presentations on the following panels, which are part of the Achieving Regulatory Approval Breakout Session:

-- Regulatory Best Practices for Emerging Companies and First-Time Filers

Panelist: David Morse, Principal Consultant, PAREXEL Consulting

(8:00 a.m. - 9:30 a.m.)

-- Is Gaining Drug Approval More Difficult in Europe than the U.S., or Vise Versa?

Panelist: Alberto Grignolo, Ph.D., Corporate Vice President, PAREXEL Consulting

(4:00 p.m. - 5:30 p.m.)

PAREXEL has worked with the top 10 global biotechnology companies, and has helped hundreds of small and mid-size biopharmaceutical companies develop and implement product and regulatory strategies as well as maximize product value at every milestone and phase of development. For information regarding PAREXEL Consulting's development optimization capabilities, including regulatory services, visit http://www.parexelconsulting.com/services/development-optimization.html.

For more information about the BIO International Convention, which brings together 20,000 life sciences professionals from 60 countries, visit http://convention.bio.org.

About PAREXEL Consulting

PAREXEL Consulting, a division of PAREXEL International, provides integrated product development services with the goal of helping biopharmaceutical and medical device companies get their products to the market, and keep them on the market. Through a unique fusion of scientific, regulatory, and business expertise PAREXEL Consulting helps clients worldwide manage risk and maximize product and portfolio value at every milestone and during each phase of development.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 69 locations throughout 52 countries around the world, and has over 9,400 employees. For more information about PAREXEL International visit www.PAREXEL.com.